'Huge therapeutic potential': University of Sask. researchers make progress on stroke treament

SASKATOON – A drug typically used to treat schizophrenia is showing positive signs during early stages of research, bringing down stroke-related swelling in the brain.

The research is being conducted by the researchers from the University of Saskatchewan, Columbia University, and the University of Oxford with help from the Canadian Light Source involves a drug called trifluoperazine (TFP).


This topic was automatically closed 14 days after the last reply. New replies are no longer allowed.